Alexion Pharmaceuticals, Inc. ALXNposted first-quarter 2018 adjusted earnings of $1.68 per share which were higher than the year-ago earnings of $1.38 by 22%. Earnings also beat the Zacks Consensus Estimate of $1.48. Strong product revenues drove the bottom line in the quarter.
Alexion's (ALXN) Earnings Beat Estimates in Q1, Guidance Up
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться